Demographic and Clinical Variables | N (%) | Mean (SD) |
---|---|---|
Age | 60.3 (11.31) | |
20–29 | 2 (2) | |
30–39 | 4 (3) | |
40–49 | 15 (12) | |
50–59 | 29 (24) | |
60–69 | 47 (39) | |
70–79 | 20 (16) | |
80–89 | 5 (4) | |
Gender | ||
Women | 95 (77.9) | |
Men | 27 (22.1) | |
Race | ||
White | 112 (91.8) | |
Indigenous | 5 (4.1) | |
Black | 1 (.8) | |
West Indian | 1 (.8) | |
Multiracial | 2 (1.7) | |
Unspecified | 1 (.8) | |
Years of education | 15.92 (3.03) | |
Cancer type | ||
Breast | 55 (45.1) | |
Colon/Rectal | 4 (3.3) | |
Head/Neck | 4 (3.3) | |
Prostate | 9 (7.3) | |
Hematological | 17 (13.9) | |
Uterine | 7 (5.7) | |
Skin | 9 (7.3) | |
Other✝ | 17 (13.9) | |
Multiple types | 21 (17.2) | |
Anxiety** | ||
Pre-treatment | ||
No anxiety | 41 (34) | |
Borderline | 33 (39) | |
Anxiety | 48 (39) | |
Mid-treatment | ||
No anxiety | 67 (55) | |
Borderline | 27 (22) | |
Anxiety | 28 (23) | |
Post-treatment | ||
No anxiety | 73 (61) | |
Borderline | 24 (20) | |
Anxiety | 23 (19) | |
Depression** | ||
Pre-treatment | ||
No depression | 69 (57) | |
Borderline | 29 (24) | |
Depression | 24 (20) | |
Mid-treatment | ||
No depression | 96 (79) | |
Borderline | 18 (15) | |
Depression | 8 (7) | |
Post-treatment | ||
No depression | 104 (87) | |
Borderline | 14 (12) | |
Depression | 2 (2) |